Myriad Genetics | MYGN - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 9M 2026-03
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Danaher USD 52.58B 368M 2026-06
Illumina USD 899M 47M 2026-06
J&J USD 17.83B 388M 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.58B 88M 2026-06
Quidel USD 646.2M 1.21B 2026-06
Repligen USD 183M 8.72M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Standard Biotools USD 30.56M 15.16M 2026-03
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Veracyte USD 126.36M 6.37M 2026-06
Waters USD 527M 592M 2026-06